Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery
Background Ovarian cancer is the seventh most common cancer among women and a
leading cause of death from gynaecological malignancies. Epithelial ovarian cancer is the …
leading cause of death from gynaecological malignancies. Epithelial ovarian cancer is the …
Minimal residual disease at primary debulking surgery versus complete tumor resection at interval debulking surgery in advanced epithelial ovarian cancer: A survival …
V Ghirardi, MC Moruzzi, N Bizzarri, V Vargiu… - Gynecologic …, 2020 - Elsevier
Objectives To compare survival outcomes and peri-operative complications in patients with
advanced ovarian cancer with 1–10 mm residual disease (RD) at primary debulking surgery …
advanced ovarian cancer with 1–10 mm residual disease (RD) at primary debulking surgery …
ENDOGRADE: A four level classification to rate surgical complexity in endometriosis
A Crestani, Y Dabi, S Bendifallah, K Kolanska… - Journal of gynecology …, 2023 - Elsevier
Objectives We studied a post operative classification of surgical complexity in endometriosis.
Study design Retrospective monocentric observational study was conducted between …
Study design Retrospective monocentric observational study was conducted between …
[PDF][PDF] Evolving concepts in the management of newly diagnosed, epithelial ovarian cancer
C Gourley, MA Bookman - Journal of Clinical Oncology, 2019 - research.ed.ac.uk
Clinical research over the last 30 years has delivered meaningful improvements in
progression-free survival (PFS), overall survival (OS), and quality of life for women with …
progression-free survival (PFS), overall survival (OS), and quality of life for women with …
Primary conization overcomes the risk of developing local recurrence following laparoscopic radical hysterectomy in early stage cervical cancer
Objective To investigate whether primary conization might overcome the risk of local
dissemination in patients undergoing laparoscopic radical hysterectomy. Methods …
dissemination in patients undergoing laparoscopic radical hysterectomy. Methods …
Robotic interval debulking surgery for advanced epithelial ovarian cancer: current challenge or future direction? A systematic review
V Psomiadou, A Prodromidou, A Fotiou, S Lekka… - Journal of Robotic …, 2021 - Springer
We evaluated the effectiveness, safety and efficacy of robotic interval debulking surgery
(IDS) in advanced epithelial ovarian cancer (EOC) treated with neoadjuvant chemotherapy …
(IDS) in advanced epithelial ovarian cancer (EOC) treated with neoadjuvant chemotherapy …
The impact of varying levels of residual disease following cytoreductive surgery on survival outcomes in patients with ovarian cancer: a meta-analysis
DM Chase, A Mahajan, DA Scott, N Hawkins… - BMC Women's …, 2024 - Springer
Background Residual disease following cytoreductive surgery in patients with ovarian
cancer has been associated with poorer survival outcomes compared with no residual …
cancer has been associated with poorer survival outcomes compared with no residual …
Association of mu-opioid receptor expression with long-term survival and perineural nerve invasion in patients undergoing surgery for ovarian cancer
H Zhang, M Qu, C Sun, Y Wang, T Li, W Xu… - Frontiers in …, 2022 - frontiersin.org
Background Opioids are widely used during primary debulking surgery (PDS) for ovarian
cancers, and a high mu-opioid receptor (MOR) expression predicts worse cancer outcomes …
cancers, and a high mu-opioid receptor (MOR) expression predicts worse cancer outcomes …
Rethinking radical surgery in interval debulking surgery for advanced-stage ovarian cancer patients undergoing neoadjuvant chemotherapy
YJ Lee, JY Lee, EJ Nam, SW Kim, S Kim… - Journal of Clinical …, 2020 - mdpi.com
The aim of this study is to evaluate the effects on survival outcomes of the disease burden
before interval debulking surgery (IDS), surgical complexity, and residual disease after IDS …
before interval debulking surgery (IDS), surgical complexity, and residual disease after IDS …
The use of artificial intelligence for complete cytoreduction prediction in epithelial ovarian cancer: A narrative review
G Parpinel, ME Laudani, E Piovano, P Zola… - Cancer …, 2023 - journals.sagepub.com
Introduction In patients affected by epithelial ovarian cancer (EOC) complete cytoreduction
(CC) has been associated with higher survival outcomes. Artificial intelligence (AI) systems …
(CC) has been associated with higher survival outcomes. Artificial intelligence (AI) systems …